Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated with Human Preeclampsia and Sufficient to Cause Features of the Disorder in Mice

Research output: Contribution to journalArticle

Authors

External Institution(s)

  • University of Iowa
  • Medical College of Wisconsin

Details

Original languageEnglish (US)
Pages (from-to)569-579
Number of pages11
JournalHypertension
StatusPublished - Feb 1 2020
Peer-reviewedYes

Abstract

Cascade-specific termination of G protein signaling is catalyzed by the RGS (regulator of G protein signaling) family members, including RGS2. Angiotensin, vasopressin, and endothelin are implicated in preeclampsia, and RGS2 is known to inhibit G protein cascades activated by these hormones. Mutations in RGS2 are associated with human hypertension and increased risk of developing preeclampsia and its sequelae. RGS family members are known to influence maternal vascular function, but the role of RGS2 within the placenta has not been explored. Here, we hypothesized that reduced expression of RGS2 within the placenta represents a risk factor for the development of preeclampsia. Although cAMP/CREB signaling was enriched in placentas from human pregnancies affected by preeclampsia compared with clinically matched controls and RGS2 is known to be a CREB-responsive gene, RGS2 mRNA was reduced in placentas from pregnancies affected by preeclampsia. Experimentally reducing Rgs2 expression within the feto-placental unit was sufficient to induce preeclampsia-like phenotypes in pregnant wild-type C57BL/6J mice. Stimulation of RGS2 transcription within immortalized human HTR8/SVneo trophoblasts by cAMP/CREB signaling was discovered to be dependent on the activity of histone deacetylase activity, and more specifically, HDAC9 (histone deacetylase-9), and HDAC9 expression was reduced in placentas from human pregnancies affected by preeclampsia. We conclude that reduced expression of RGS2 within the placenta may mechanistically contribute to preeclampsia. More generally, this work identifies RGS2 as an HDAC9-dependent CREB-responsive gene, which may contribute to reduced RGS2 expression in placenta during preeclampsia.

    Research areas

  • GTP-binding proteins, hypertension, placenta, preeclampsia, pregnancy

Citation formats

APA

Harvard

Perschbacher, KJ, Deng, G, Sandgren, JA, Walsh, JW, Witcher, PC, Sapouckey, SA, Owens, CE, Zhang, SY, Scroggins, SM, Pearson, NA, Devor, EJ, Sebag, JA, Pierce, GL, Fisher, RA, Kwitek, AE, Santillan, DA, Gibson-Corley, KN, Sigmund, CD, Santillan, MK & Grobe, JL 2020, 'Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated with Human Preeclampsia and Sufficient to Cause Features of the Disorder in Mice', Hypertension, pp. 569-579. https://doi.org/10.1161/HYPERTENSIONAHA.119.14056